1
|
Rodríguez de Santiago E, Herreros-de-Tejada A, Albéniz E, Ramos Zabala F, Fernández-Esparrach G, Nogales O, Rosón P, Peñas García B, Uchima H, Terán Á, Rodríguez Sánchez J, de Frutos D, Parejo Carbonell S, Santiago J, Díaz Tasende J, Guarner Argente C, de María Pallarés P, Amorós A, Barranco D, Álvarez de Castro D, Muñoz González R, Marín-Gabriel JC. Implementation of esophageal endoscopic submucosal dissection in Spain: Results from the nationwide registry. Gastroenterol Hepatol 2024; 47:119-129. [PMID: 36870477 DOI: 10.1016/j.gastrohep.2023.02.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/21/2022] [Revised: 01/24/2023] [Accepted: 02/21/2023] [Indexed: 03/06/2023]
Abstract
INTRODUCTION AND AIMS The outcomes of endoscopic submucosal dissection (ESD) in the esophagus have not been assessed in our country. Our primary aim was to analyze the effectiveness and safety of the technique. MATERIAL AND METHODS Analysis of the prospectively maintained national registry of ESD. We included all superficial esophageal lesions removed by ESD in 17 hospitals (20 endoscopists) between January 2016 and December 2021. Subepithelial lesions were excluded. The primary outcome was curative resection. We conducted a survival analysis and used logistic regression analysis to assess predictors of non-curative resection. RESULTS A total of 102 ESD were performed on 96 patients. The technical success rate was 100% and the percentage of en-bloc resection was 98%. The percentage of R0 and curative resection was 77.5% (n=79; 95%CI: 68%-84%) and 63.7% (n=65; 95%CI: 54%-72%), respectively. The most frequent histology was Barrett-related neoplasia (n=55 [53.9%]). The main reason for non-curative resection was deep submucosal invasion (n=25). The centers with a lower volume of ESD obtained worse results in terms of curative resection. The rate of perforation, delayed bleeding and post-procedural stenosis were 5%, 5% and 15.7%, respectively. No patient died or required surgery due to an adverse effect. After a median follow-up of 14months, 20patients (20.8%) underwent surgery and/or chemoradiotherapy, and 9 patients died (mortality 9.4%). CONCLUSIONS In Spain, esophageal ESD is curative in approximately two out of three patients, with an acceptable risk of adverse events.
Collapse
Affiliation(s)
- Enrique Rodríguez de Santiago
- Servicio de Gastroenterología y Hepatología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, España.
| | - Alberto Herreros-de-Tejada
- Servicio de Digestivo, Hospital Universitario Puerta de Hierro, Instituto de Investigación Puerta de Hierro-Segovia de Arana (IDIPHISA), Majadahonda, Madrid, España; Hospital La Luz, QuirónSalud, Madrid, España
| | - Eduardo Albéniz
- Unidad de Endoscopia, Servicio de Gastroenterología, Hospital Universitario de Navarra NavarraBiomed, Universidad Pública de Navarra (UPNA), IdisNA, Pamplona, España
| | - Felipe Ramos Zabala
- Servicio de Gastroenterología, Hospital Universitario HM Montepríncipe, Grupo HM hospitales, Boadilla del Monte, Madrid, España
| | - Gloria Fernández-Esparrach
- Sección de Endoscopia, Servicio de Gastroenterología, ICMDM, Hospital Clínic de Barcelona; Institut d'Investigacions Biomèdiques August Pi i Sunyer. CIBEREHD. Universidad de Barcelona, Barcelona, España
| | - Oscar Nogales
- Servicio de Gastroenterología, Hospital General Universitario Gregorio Marañón, Madrid, España
| | - Pedro Rosón
- Servicio de Aparato Digestivo, Hospital Vithas Xanit internacional Málaga, Málaga, España
| | - Beatriz Peñas García
- Servicio de Gastroenterología y Hepatología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, España
| | - Hugo Uchima
- Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, España; Centro Médico Teknon, Barcelona, España
| | - Álvaro Terán
- Servicio de Gastroenterología, Hospital Universitario Marqués de Valdecilla, Instituto de Investigación Valdecilla (IDIVAL), Santander, España
| | - Joaquín Rodríguez Sánchez
- Servicio de Medicina del Aparato Digestivo, Unidad de Endoscopias, Hospital Universitario 12 de Octubre; Instituto de Investigación «i+12», Madrid, España; Servicio de Gastroenterología, Hospital General Universitario de Ciudad Real, Ciudad Real, España
| | - Diego de Frutos
- Servicio de Digestivo, Hospital Universitario Puerta de Hierro, Instituto de Investigación Puerta de Hierro-Segovia de Arana (IDIPHISA), Majadahonda, Madrid, España
| | - Sofía Parejo Carbonell
- Servicio de Gastroenterología y Hepatología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, España
| | - José Santiago
- Servicio de Digestivo, Hospital Universitario Puerta de Hierro, Instituto de Investigación Puerta de Hierro-Segovia de Arana (IDIPHISA), Majadahonda, Madrid, España
| | - José Díaz Tasende
- Servicio de Medicina del Aparato Digestivo, Unidad de Endoscopias, Hospital Universitario 12 de Octubre; Instituto de Investigación «i+12», Madrid, España
| | - Charly Guarner Argente
- Servicio de Gastroenterología, Hospital de la Santa Creu i Sant Pau, Universitat Autónoma de Barcelona, Barcelona, España
| | | | - Ana Amorós
- Servicio de Gastroenterología, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, España
| | - Daniel Barranco
- Unidad de Endoscopia, Servicio de Gastroenterología, Hospital Universitario de Navarra NavarraBiomed, Universidad Pública de Navarra (UPNA), IdisNA, Pamplona, España
| | - Daniel Álvarez de Castro
- Servicio de Gastroenterología y Hepatología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, España
| | - Raquel Muñoz González
- Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, España; Centro Médico Teknon, Barcelona, España
| | - José Carlos Marín-Gabriel
- Servicio de Medicina del Aparato Digestivo, Unidad de Endoscopias, Hospital Universitario 12 de Octubre; Instituto de Investigación «i+12», Madrid, España
| |
Collapse
|
2
|
Alía Navarro V, Martínez Delfrade Í, De Frutos González B, Morón García B, Barrill Corpa AM, Sotoca Rubio P, Peñas García B, Ferrer Gómez A, Perna Monroy C, Ferreiro Monteagudo R. Localized Colonic Small-Cell Carcinoma with Pathological Complete Response after Neoadjuvant Cisplatin and Etoposide: A Case Report. Curr Oncol 2023; 30:8426-8433. [PMID: 37754528 PMCID: PMC10528221 DOI: 10.3390/curroncol30090613] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2023] [Revised: 09/01/2023] [Accepted: 09/12/2023] [Indexed: 09/28/2023] Open
Abstract
Extrapulmonary small-cell carcinoma (SCC) is a rare neoplasm that shares certain features with its pulmonary counterpart and occurs predominantly in the gastrointestinal tract (GIT). It is a high-grade and poorly differentiated neuroendocrine tumor, usually diagnosed in advanced stages, with a poor prognosis and few therapeutic options in that setting. This is a case report of a 77-year-old Spanish male patient with localized SCC of the colon, who presented a pathological complete response in the surgical specimen after neoadjuvant chemotherapy with cisplatin and etoposide. To date, 5 years after surgery, the patient remains without evidence of tumor recurrence. As clinical guidelines for the management of this entity are lacking, and therefore its management has not been standardized, an attempt to summarize the current evidence in the literature was made.
Collapse
Affiliation(s)
- Víctor Alía Navarro
- Medical Oncology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain (R.F.M.)
| | - Íñigo Martínez Delfrade
- Medical Oncology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain (R.F.M.)
- Ramón y Cajal Health Research Institute (IRYCIS), 28034 Madrid, Spain
| | - Belén De Frutos González
- Medical Oncology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain (R.F.M.)
- Ramón y Cajal Health Research Institute (IRYCIS), 28034 Madrid, Spain
| | - Blanca Morón García
- Medical Oncology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain (R.F.M.)
- Ramón y Cajal Health Research Institute (IRYCIS), 28034 Madrid, Spain
| | - Ana María Barrill Corpa
- Medical Oncology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain (R.F.M.)
| | - Pilar Sotoca Rubio
- Medical Oncology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain (R.F.M.)
| | - Beatriz Peñas García
- Gastroenterology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain
| | - Ana Ferrer Gómez
- Pathology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain
| | | | - Reyes Ferreiro Monteagudo
- Medical Oncology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain (R.F.M.)
- Ramón y Cajal Health Research Institute (IRYCIS), 28034 Madrid, Spain
- Biomedical Research Network in Cancer (CIBERONC), 28029 Madrid, Spain
| |
Collapse
|
3
|
Villaescusa Arenas D, Rodríguez de Santiago E, Rodríguez Gandía MÁ, Parejo Carbonell S, Peñas García B, Guerrero García A, Foruny Olcina JR, García García de Paredes A, González Martín JÁ, Vázquez-Sequeiros E, Albillos A. Over-the-scope-clip (OTSC®) as a rescue treatment for gastrointestinal bleeding secondary to peptic ulcer disease. Rev Esp Enferm Dig 2023; 115:70-74. [PMID: 35469413 DOI: 10.17235/reed.2022.8722/2022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
BACKGROUND AND AIMS over-the-scope-clips (OTSC®) have been proposed as a rescue treatment for bleeding peptic ulcers. However, their effectiveness has not been evaluated in Spain. METHODS this retrospective and single-center study (January 2018-December 2021) assessed the technical success, clinical success and safety of the device within 30 days. All patients with upper gastrointestinal bleeding due to a peptic ulcer and treated with the OTSC® clip (OVESCO) as a rescue therapy were included in the study. RESULTS a total of eleven patients were included in the study, nine due to rebleeding and two due to persistent bleeding. Technical success was 81.9 % (9/11, confidence interval [CI] 95 %: 52-95 %). The per-protocol and intention-to-treat clinical success were 88.9 % (8/9, CI 95 %: 57-98 %) and 72.7 % (8/11, CI 95 %: 43-90 %), respectively. No device-related adverse effects were recorded. CONCLUSION the OTSC® clip was an effective and safe rescue therapy for bleeding peptic ulcers.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | - Agustín Albillos
- Gastroenterología y Hepatología, Hospital Universitario Ramón y Cajal
| |
Collapse
|
4
|
Rodríguez de Santiago E, Téllez Villajos L, Peñas García B, Foruny Olcina JR, García García de Paredes A, Ferre Aracil C, Albillos Martínez A. Acute necrotizing pancreatitis and sudden abdominal mass: An unusual complication. Gastroenterol Hepatol 2017; 40:292-293. [PMID: 26952581 DOI: 10.1016/j.gastrohep.2016.01.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/06/2015] [Revised: 01/13/2016] [Accepted: 01/25/2016] [Indexed: 06/05/2023]
Affiliation(s)
| | - Luis Téllez Villajos
- Servicio de Gastroenterología, Hospital Universitario Ramón y Cajal, Madrid, España
| | - Beatriz Peñas García
- Servicio de Gastroenterología, Hospital Universitario Ramón y Cajal, Madrid, España; Instituto Universitario Ramón y Cajal (IRICYS), Universidad de Alcalá de Henares, Alcalá de Henares, Madrid, España
| | | | | | - Carlos Ferre Aracil
- Servicio de Gastroenterología, Hospital Universitario Ramón y Cajal, Madrid, España
| | - Agustín Albillos Martínez
- Servicio de Gastroenterología, Hospital Universitario Ramón y Cajal, Madrid, España; Instituto Universitario Ramón y Cajal (IRICYS), Universidad de Alcalá de Henares, Alcalá de Henares, Madrid, España
| |
Collapse
|
5
|
Rodríguez de Santiago E, Zaera de la Fuente C, Peñas García B, Gutiérrez-Pecharromán AM, Cuño Roldán JL, Arocena Aranguren C, Defarges Pons V, Aguilera Castro L, Boixeda de Miquel D, Albillos Martínez A. Ulcerated submucosal gastric tumor. Could it be a benign condition? Rev Esp Enferm Dig 2016; 108:733-735. [PMID: 27822953] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
In this article we present the case and images of an infrequent submucosal gastric tumor: an inflammatory fibroid polyp or Vanek´s tumor. When the tumor size exceeds the centimeter, it may be difficult to differentiate from malignant lesions. Endoscopic removal may be feasible and curative.
Collapse
Affiliation(s)
| | - Celia Zaera de la Fuente
- Gastroenterología y Hepatología, Hospital Universitario Ramón y Cajal. Universidad de Alcalá. IRICYS
| | - Beatriz Peñas García
- Gastroenterología y Hepatología, Hospital Universitario Ramón y Cajal. Universidad de Alcalá. IRICYS, España
| | | | | | | | | | | | - Daniel Boixeda de Miquel
- Gastroenterología y Hepatología, Hospital Universitario Ramón y Cajal. Universidad de Alcalá. IRICYS, España
| | - Agustín Albillos Martínez
- Gastroenterología y Hepatología, Hospital Universitario Ramón y Cajal. Universidad de Alcalá. IRICYS, España
| |
Collapse
|